Help for people whose HIV treatment is not working
Part of Immune system & allergy, Infections clinical trials.
This trial tests different ways to manage “virologic failure,” meaning HIV viral load stays high while taking TLD (a common HIV medicine combination). It may help people better control the virus and improve treatment results, especially in parts of sub-Saharan Africa.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 15 or older
- Be enrolled in HIV care at a study clinic
- While on TLD, have had two viral load tests showing HIV levels above 1,000 copies/mL
- Have been taking TLD for at least 12 months
- Live within 100 kilometers of the study clinic
- You should be able to stay with the same clinic for the next 48 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study (not a new drug) that tracks how living with HIV can change over time in different treatment situations. It may help researchers understand long-term effects of the modern “protease inhibitor era” and improve future care.
This trial tests a new type of medicine that aims to wake up HIV hiding in your body's cells by targeting a viral protein called Tat. The goal is to help find a way to clear the virus completely.
This study looks at HIV drug resistance in people whose current HIV treatment is not keeping the virus under control. It helps doctors understand why some treatments stop working and how to choose better next steps.
This trial tests better ways to manage HIV when the virus becomes resistant to dolutegravir (DTG), a key medicine. It is for people with high viral load despite being on DTG for at least six months.
This trial is for people who got exposed to HIV despite taking the long-acting PrEP shot (cabotegravir). It tests different pill-based HIV treatment plans to find the best option for them.
This study tests a new long-acting HIV medication taken by mouth that may allow you to switch from your current daily pill. It is for people who have had an undetectable HIV viral load for at least 6 months and are currently on a stable HIV treatment.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.